Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, and 2,6-diaminopurines (Q44572508)

4 December 2017

title

Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, and 2,6-diaminopurines (English)

1 reference

4 December 2017

Antonín Holý

1 reference

4 December 2017

Zdenek Zídek

1 reference

4 December 2017

Petr Potmesil

series ordinal

1 reference

4 December 2017

Eva Kmoníèková

series ordinal

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

European Journal of Pharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

475

1 reference

4 December 2017

issue

1-3

1 reference

4 December 2017

page(s)

149-159

1 reference

Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Cellular responses to interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Macrophage deactivation by interleukin 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

New reverse transcriptase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Cidofovir in the treatment of poxvirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Host factors and the pathogenesis of HIV-induced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Nitric oxide synthase: expression and expressional control of the three isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Effects of tumor necrosis factor alpha on replication of varicella-zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Inhibition of Viral Replication by Interferon-γ-Induced Nitric Oxide Synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Role of nitric oxide synthesis in macrophage antimicrobial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Treatment of experimental viral myocarditis with interleukin-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Nitric oxide inhibits HIV-1 replication in human astrocytoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Interleukin 10 increases CCR5 expression and HIV infection in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine on visna virus infection in lambs: a model for in vivo testing of candidate anti-human immunodeficiency virus drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Expression of the HIV-1 co-receptors CCR5 and CXCR4 on placental macrophages and the effect of IL-10 on their expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Biology of natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Inhibition of avian myeloblastosis virus reverse transcriptase by diphosphates of acyclic phosphonylmethyl nucleotide analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Constitutive cell surface association between CD4 and CCR5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Stimulation of cytokine and nitric oxide production by acyclic nucleoside phosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902110-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(03)02110-1

1 reference

4 December 2017

1 reference